Skip to content

Siren, L.L.C.

Follow

13F filer, CIK 2005245, New York, NY

Siren, L.L.C. reported $4,231,656,130 across 111 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-12. Its ten largest share positions make up 47.39% of the portfolio.

Accepted , ingested 13F-HR 0002005245-26-000013

Period
2026-09-30
Reported value
$4.23B
Holdings
111
Top 10 weight
47.39%
New
18
Sold out
24

Largest buys vs the previous quarter

SecurityShares changeApprox. value
TYRAadded+2,670,887$58.4M
ADRXnew+1,925,794$38.4M
ARWRadded+575,000$37.6M
ASNDnew+130,000$29.6M
AMLXadded+1,000,000$29.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
DFTXexited-1,419,493-$66.8M
CRNXexited-1,420,788-$53.2M
MANEreduced-331,075-$40.1M
ABVXreduced-388,000-$38.4M
COFexited-171,615-$34.4M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0002005245-26-000013, largest first. % of portfolio is the value over $4,219,346,530, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
SRRKSCHOLAR ROCK HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 9,250,005 shares; 2025Q1: 9,250,005 shares; 2025Q2: 9,250,005 shares; 2025Q3: 9,250,005 shares; 2025Q4: 10,825,013 shares; 2026Q1: 10,825,013 shares; 2026Q2: 9,575,013 shares; 2026Q3: 9,375,013 shares 9,375,013$453M10.74%-200,000Timeline
KYMRKYMERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,969,733 shares; 2025Q1: 3,240,313 shares; 2025Q2: 3,428,150 shares; 2025Q3: 3,428,150 shares; 2025Q4: 3,286,830 shares; 2026Q1: 3,186,830 shares; 2026Q2: 2,935,830 shares; 2026Q3: 2,784,898 shares 2,784,898$311M7.38%-150,932Timeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,857,179 shares; 2025Q1: 8,757,249 shares; 2025Q2: 8,757,249 shares; 2025Q3: 8,757,249 shares; 2025Q4: 8,757,249 shares; 2026Q1: 11,244,246 shares; 2026Q2: 11,397,781 shares; 2026Q3: 13,197,781 shares 13,197,781$193M4.59%+1,800,000Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 571,548 shares; 2025Q1: 563,755 shares; 2025Q2: 938,755 shares; 2025Q3: 1,043,720 shares; 2025Q4: 1,335,075 shares; 2026Q1: 1,110,980 shares; 2026Q2: 900,000 shares; 2026Q3: 850,000 shares 850,000$174M4.14%-50,000Timeline
ONCBEONE MEDICINES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 653,721 shares; 2025Q1: 498,689 shares; 2025Q2: 509,990 shares; 2025Q3: 492,990 shares; 2025Q4: 500,000 shares; 2026Q1: 465,000 shares; 2026Q2: 465,000 shares; 2026Q3: 465,000 shares 465,000$170M4.03%0Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,603,897 shares; 2025Q1: 2,565,342 shares; 2025Q2: 3,364,814 shares; 2025Q3: 5,883,188 shares; 2025Q4: 8,165,374 shares; 2026Q1: 5,657,105 shares; 2026Q2: 6,179,364 shares; 2026Q3: 6,784,081 shares 6,784,081$169M4.01%+604,717Timeline
MANEVERADERMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,505,374 shares; 2026Q2: 1,655,374 shares; 2026Q3: 1,324,299 shares 1,324,299$161M3.8%-331,075Timeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,901,681 shares; 2025Q1: 2,669,880 shares; 2025Q2: 2,669,880 shares; 2025Q3: 2,669,880 shares; 2025Q4: 1,500,476 shares; 2026Q1: 1,615,476 shares; 2026Q2: 1,715,476 shares; 2026Q3: 2,290,476 shares 2,290,476$150M3.55%+575,000Timeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 734,343 shares; 2025Q1: 1,696,444 shares; 2025Q2: 3,160,298 shares; 2025Q3: 3,897,099 shares; 2025Q4: 4,529,990 shares; 2026Q1: 4,430,263 shares; 2026Q2: 3,184,629 shares; 2026Q3: 2,804,179 shares 2,804,179$114M2.7%-380,450Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 277,533 shares; 2025Q2: 409,742 shares; 2025Q3: 499,975 shares; 2025Q4: 499,975 shares; 2026Q1: 725,511 shares; 2026Q2: 1,136,275 shares; 2026Q3: 1,086,275 shares 1,086,275$103M2.45%-50,000Timeline
BCAXBICARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,272,827 shares; 2025Q1: 3,267,083 shares; 2025Q2: 5,216,969 shares; 2025Q3: 5,216,969 shares; 2025Q4: 5,216,969 shares; 2026Q1: 5,802,970 shares; 2026Q2: 5,602,970 shares; 2026Q3: 5,502,970 shares 5,502,970$102M2.43%-100,000Timeline
PBLSPARABILIS MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,992,259 shares; 2026Q3: 2,992,259 shares 2,992,259$96.6M2.29%0Timeline
LXRXLEXICON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 38,918,903 shares; 2025Q1: 38,918,903 shares; 2025Q2: 38,918,903 shares; 2025Q3: 38,918,903 shares; 2025Q4: 38,918,903 shares; 2026Q1: 44,303,518 shares; 2026Q2: 44,303,518 shares; 2026Q3: 44,303,518 shares 44,303,518$83.3M1.97%0Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 374,000 shares; 2025Q1: 368,598 shares; 2025Q2: 368,598 shares; 2025Q3: 368,598 shares; 2025Q4: 818,598 shares; 2026Q1: 818,598 shares; 2026Q2: 968,598 shares; 2026Q3: 868,598 shares 868,598$77.3M1.83%-100,000Timeline
TYRATYRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 725,000 shares; 2026Q3: 3,395,887 shares 3,395,887$74.3M1.76%+2,670,887Timeline
COAGHEMAB THERAPEUTICS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,086,834 shares; 2026Q3: 2,366,235 shares 2,366,235$73M1.73%+279,401Timeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,230,000 shares; 2026Q2: 1,480,586 shares; 2026Q3: 2,480,586 shares 2,480,586$72.2M1.71%+1,000,000Timeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 746,226 shares; 2026Q2: 1,774,411 shares; 2026Q3: 1,475,163 shares 1,475,163$67.6M1.6%-299,248Timeline
SEPNSEPTERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,202,514 shares; 2025Q1: 2,202,514 shares; 2025Q2: 2,202,514 shares; 2025Q3: 2,202,514 shares; 2025Q4: 2,000,000 shares; 2026Q1: 2,000,000 shares; 2026Q2: 1,900,000 shares; 2026Q3: 1,700,000 shares 1,700,000$66.5M1.58%-200,000Timeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,612,077 shares; 2025Q1: 1,612,077 shares; 2025Q2: 1,612,077 shares; 2025Q3: 2,912,077 shares; 2025Q4: 3,007,077 shares; 2026Q1: 3,007,077 shares; 2026Q2: 2,420,430 shares; 2026Q3: 2,420,430 shares 2,420,430$62.5M1.48%0Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,650,000 shares; 2026Q3: 3,262,976 shares 3,262,976$58.9M1.4%-387,024Timeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 1,071,865 shares; 2025Q2: 1,099,401 shares; 2025Q3: 913,401 shares; 2025Q4: 988,401 shares; 2026Q1: 988,401 shares; 2026Q2: 888,401 shares; 2026Q3: 888,401 shares 888,401$58.2M1.38%0Timeline
SLDBSOLID BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,749,041 shares; 2025Q1: 7,415,905 shares; 2025Q2: 7,415,905 shares; 2025Q3: 7,415,905 shares; 2025Q4: 7,690,405 shares; 2026Q1: 7,690,405 shares; 2026Q2: 7,690,405 shares; 2026Q3: 7,690,405 shares 7,690,405$55.6M1.32%0Timeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,000,000 shares; 2025Q1: 2,247,347 shares; 2025Q2: 2,247,347 shares; 2025Q3: 2,247,347 shares; 2025Q4: 2,247,347 shares; 2026Q1: 1,995,347 shares; 2026Q2: 1,995,347 shares; 2026Q3: 1,995,347 shares 1,995,347$51.9M1.23%0Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 854,379 shares; 2025Q3: 1,724,279 shares; 2025Q4: 1,629,279 shares; 2026Q1: 1,709,279 shares; 2026Q2: 1,859,279 shares; 2026Q3: 1,609,279 shares 1,609,279$51.5M1.22%-250,000Timeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,602,475 shares; 2025Q1: 6,514,737 shares; 2025Q2: 11,014,737 shares; 2025Q3: 11,014,737 shares; 2025Q4: 10,129,913 shares; 2026Q1: 8,829,913 shares; 2026Q2: 9,846,579 shares; 2026Q3: 9,846,579 shares 9,846,579$48M1.14%0Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 402,323 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 613,952 shares; 2026Q2: 758,952 shares; 2026Q3: 708,952 shares 708,952$46.7M1.11%-50,000Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,007,575 shares; 2025Q1: 1,007,575 shares; 2025Q2: 1,007,575 shares; 2025Q3: 1,007,575 shares; 2025Q4: 1,007,575 shares; 2026Q1: 2,998,192 shares; 2026Q2: 2,998,192 shares; 2026Q3: 3,358,192 shares 3,358,192$45.2M1.07%+360,000Timeline
OLMAOLEMA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,300,700 shares; 2026Q1: 4,756,949 shares; 2026Q2: 4,856,949 shares; 2026Q3: 4,856,949 shares 4,856,949$42M0.99%0Timeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,347,456 shares; 2025Q1: 2,717,987 shares; 2025Q2: 4,836,437 shares; 2025Q3: 4,729,174 shares; 2025Q4: 3,502,941 shares; 2026Q1: 2,229,125 shares; 2026Q2: 2,129,125 shares; 2026Q3: 2,429,125 shares 2,429,125$39.1M0.93%+300,000Timeline
ADRXADARX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,925,794 shares 1,925,794$38.4M0.91%newTimeline
RELYREMITLY GLOBAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 490,449 shares; 2025Q1: 490,449 shares; 2025Q2: 515,449 shares; 2025Q3: 1,618,271 shares; 2025Q4: 1,618,271 shares; 2026Q1: 1,543,271 shares; 2026Q2: 1,543,271 shares; 2026Q3: 1,543,271 shares 1,543,271$32.9M0.78%0Timeline
SLNSILENCE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,831,770 shares; 2025Q1: 2,789,833 shares; 2025Q2: 2,911,438 shares; 2025Q3: 2,911,438 shares; 2025Q4: 2,911,438 shares; 2026Q1: 2,911,438 shares; 2026Q2: 3,311,438 shares; 2026Q3: 2,887,867 shares 2,887,867$31.6M0.75%-423,571Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 130,000 shares 130,000$29.6M0.7%newTimeline
DNLIDENALI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 834,028 shares; 2025Q1: 821,513 shares; 2025Q2: 821,513 shares; 2025Q3: 821,513 shares; 2025Q4: 1,396,513 shares; 2026Q1: 1,396,513 shares; 2026Q2: 1,396,513 shares; 2026Q3: 1,396,513 shares 1,396,513$28.9M0.68%0Timeline
PVLAPALVELLA THERAPEUTICS INC NEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 75,000 shares; 2026Q1: 257,485 shares; 2026Q2: 257,485 shares; 2026Q3: 207,485 shares 207,485$28.6M0.68%-50,000Timeline
DBVTDBV TECHNOLOGIES S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,857,362 shares; 2026Q1: 1,857,362 shares; 2026Q2: 1,857,362 shares; 2026Q3: 2,356,539 shares 2,356,539$27.7M0.66%+499,177Timeline
CGEMCULLINAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,211,357 shares; 2025Q1: 1,193,410 shares; 2025Q2: 1,193,410 shares; 2025Q3: 1,193,410 shares; 2025Q4: 1,193,410 shares; 2026Q1: 1,193,410 shares; 2026Q2: 1,893,410 shares; 2026Q3: 1,793,410 shares 1,793,410$27.5M0.65%-100,000Timeline
GOOGLALPHABET INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 7,000 shares; 2025Q1: 50,703 shares; 2025Q2: 50,703 shares; 2025Q3: 21,203 shares; 2025Q4: 20,703 shares; 2026Q1: 65,703 shares; 2026Q2: 90,000 shares; 2026Q3: 80,000 shares 80,000$27.5M0.65%-10,000Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,026,811 shares; 2025Q4: 1,078,698 shares; 2026Q1: 1,328,698 shares; 2026Q2: 872,967 shares; 2026Q3: 872,967 shares 872,967$27.3M0.65%0Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 743,769 shares; 2025Q1: 732,761 shares; 2025Q2: 812,761 shares; 2025Q3: 812,761 shares; 2025Q4: 812,761 shares; 2026Q1: 1,318,564 shares; 2026Q2: 1,318,564 shares; 2026Q3: 718,306 shares 718,306$26.7M0.63%-600,258Timeline
KLRAKAILERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,214,286 shares; 2026Q3: 2,214,286 shares 2,214,286$25.3M0.6%0Timeline
AGENAGENUS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 500,000 shares; 2025Q2: 1,064,250 shares; 2025Q3: 1,064,250 shares; 2025Q4: 1,064,250 shares; 2026Q1: 1,064,250 shares; 2026Q2: 1,064,250 shares; 2026Q3: 2,419,263 shares 2,419,263$24M0.57%+1,355,013Timeline
NVDANVIDIA CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 48,932 shares; 2025Q1: 44,432 shares; 2025Q2: 49,985 shares; 2025Q3: 37,485 shares; 2025Q4: 37,485 shares; 2026Q1: 89,085 shares; 2026Q2: 95,000 shares; 2026Q3: 97,500 shares 97,500$22.3M0.53%+2,500Timeline
SPTXSEAPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,095,316 shares; 2026Q3: 1,095,316 shares 1,095,316$22.1M0.52%0Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,906,060 shares; 2025Q1: 2,863,793 shares; 2025Q2: 3,938,793 shares; 2025Q3: 2,536,867 shares; 2025Q4: 2,286,867 shares; 2026Q1: 1,786,867 shares; 2026Q2: 1,786,867 shares; 2026Q3: 1,523,889 shares 1,523,889$21.8M0.52%-262,978Timeline
RAPPRAPPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 384,197 shares; 2025Q1: 378,469 shares; 2025Q2: 378,469 shares; 2025Q3: 1,053,469 shares; 2025Q4: 708,469 shares; 2026Q1: 641,469 shares; 2026Q2: 641,469 shares; 2026Q3: 641,469 shares 641,469$21.6M0.51%0Timeline
MNPRMONOPAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 212,298 shares; 2026Q1: 270,118 shares; 2026Q2: 270,118 shares; 2026Q3: 270,118 shares 270,118$21.5M0.51%0Timeline
TSMTAIWAN SEMICONDUCTOR MANUFACQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 15,000 shares; 2025Q1: 28,500 shares; 2025Q2: 30,500 shares; 2025Q3: 28,200 shares; 2025Q4: 27,700 shares; 2026Q1: 42,200 shares; 2026Q2: 44,700 shares; 2026Q3: 45,000 shares 45,000$20.5M0.49%+300Timeline
DMRADAMORA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 900,000 shares 900,000$19.2M0.45%newTimeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 576,000 shares; 2026Q3: 188,000 shares 188,000$18.6M0.44%-388,000Timeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,958,646 shares; 2026Q2: 4,458,646 shares; 2026Q3: 4,359,560 shares 4,359,560$18.4M0.44%-99,086Timeline
ENTXENTERA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 736,457 shares; 2026Q3: 6,000,000 shares 6,000,000$17.5M0.41%+5,263,543Timeline
MSFTMICROSOFT CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 23,000 shares; 2025Q1: 28,500 shares; 2025Q2: 16,150 shares; 2025Q3: 17,150 shares; 2025Q4: 15,000 shares; 2026Q1: 41,380 shares; 2026Q2: 37,500 shares; 2026Q3: 34,000 shares 34,000$17.4M0.41%-3,500Timeline
ZURAZURA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,300,000 shares; 2026Q1: 3,734,866 shares; 2026Q2: 3,734,866 shares; 2026Q3: 3,734,866 shares 3,734,866$15.5M0.37%0Timeline
YARWYARROW BIOSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 675,000 shares 675,000$15.2M0.36%newTimeline
ABSIABSCI CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,800,000 shares; 2026Q2: 2,474,764 shares; 2026Q3: 1,374,764 shares 1,374,764$14.8M0.35%-1,100,000Timeline
SKHYSK HYNIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 80,000 shares 80,000$14.7M0.35%newTimeline
TBLATABOOLA.COM LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 9,969,495 shares; 2025Q1: 9,969,495 shares; 2025Q2: 9,969,495 shares; 2025Q3: 9,969,495 shares; 2025Q4: 9,969,495 shares; 2026Q1: 9,969,495 shares; 2026Q2: 8,423,410 shares; 2026Q3: 4,259,868 shares 4,259,868$14.3M0.34%-4,163,542Timeline
GHRSGH RESEARCH PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 600,000 shares 600,000$14.1M0.33%newTimeline
RZLTREZOLUTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 4,870,000 shares; 2025Q4: not reported; 2026Q1: 3,328,287 shares; 2026Q2: 3,328,287 shares; 2026Q3: 3,328,287 shares 3,328,287$13.8M0.33%0Timeline
ENGNENGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 6,256,662 shares; 2026Q3: 6,256,662 shares 6,256,662$12.5M0.3%0Timeline
NOWSERVICENOW INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,605 shares; 2025Q1: 9,126 shares; 2025Q2: 5,126 shares; 2025Q3: 7,126 shares; 2025Q4: 35,630 shares; 2026Q1: 87,090 shares; 2026Q2: 100,000 shares; 2026Q3: 90,000 shares 90,000$12.1M0.29%-10,000Timeline
IKTINHIBIKASE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 5,850,000 shares; 2026Q1: 5,850,000 shares; 2026Q2: 5,850,000 shares; 2026Q3: 5,850,000 shares 5,850,000$12M0.28%0Timeline
NBISNEBIUS GROUP N.V.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 120,000 shares; 2025Q1: 140,000 shares; 2025Q2: 51,000 shares; 2025Q3: 72,600 shares; 2025Q4: 76,218 shares; 2026Q1: 113,614 shares; 2026Q2: 52,000 shares; 2026Q3: 47,500 shares 47,500$11.2M0.27%-4,500Timeline
GENBGENERATE BIOMEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 736,104 shares; 2026Q2: 736,104 shares; 2026Q3: 736,104 shares 736,104$11.1M0.26%0Timeline
DTDYNATRACE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 82,729 shares; 2025Q1: 87,729 shares; 2025Q2: 75,229 shares; 2025Q3: 100,229 shares; 2025Q4: 115,229 shares; 2026Q1: 150,000 shares; 2026Q2: 155,000 shares; 2026Q3: 190,000 shares 190,000$11M0.26%+35,000Timeline
ACRSACLARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,025,000 shares 2,025,000$10.7M0.25%newTimeline
AVGOBROADCOM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 7,000 shares; 2026Q1: 15,000 shares; 2026Q2: 25,000 shares; 2026Q3: 29,500 shares 29,500$10.4M0.25%+4,500Timeline
CTMXCYTOMX THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,457,711 shares; 2026Q2: 3,457,711 shares; 2026Q3: 3,457,711 shares 3,457,711$9.4M0.22%0Timeline
WHWKWHITEHAWK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 2,082,000 shares; 2025Q2: 2,082,000 shares; 2025Q3: 2,082,000 shares; 2025Q4: 2,082,000 shares; 2026Q1: 2,082,000 shares; 2026Q2: 2,337,102 shares; 2026Q3: 2,337,102 shares 2,337,102$8.79M0.21%0Timeline
MSLESATELLOS BIOSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 892,074 shares; 2026Q2: 892,074 shares; 2026Q3: 892,074 shares 892,074$7.58M0.18%0Timeline
IONQIONQ INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 170,000 shares; 2025Q1: 170,000 shares; 2025Q2: 170,000 shares; 2025Q3: 170,000 shares; 2025Q4: 170,000 shares; 2026Q1: 170,000 shares; 2026Q2: 170,000 shares; 2026Q3: 170,000 shares 170,000$7.46M0.18%0Timeline
DSGNDESIGN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 523,212 shares; 2026Q3: 523,212 shares 523,212$6.58M0.16%0Timeline
FROGJFROG LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 120,116 shares; 2025Q1: 131,616 shares; 2025Q2: 107,116 shares; 2025Q3: 107,116 shares; 2025Q4: 93,616 shares; 2026Q1: 128,816 shares; 2026Q2: 95,500 shares; 2026Q3: 66,500 shares 66,500$6.45M0.15%-29,000Timeline
ELOXELOXX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 400,000 shares; 2026Q3: 400,000 shares 400,000$6.12M0.15%0Timeline
OCSOCULIS HOLDING AGQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 625,000 shares; 2026Q3: 625,000 shares 625,000$5.84M0.14%0Timeline
CBIOCRESCENT BIOPHARMA INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 400,000 shares 400,000$5.84M0.14%newTimeline
AMZNAMAZON COM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 36,500 shares; 2025Q1: 56,500 shares; 2025Q2: 56,500 shares; 2025Q3: 58,500 shares; 2025Q4: 51,500 shares; 2026Q1: 46,641 shares; 2026Q2: 32,500 shares; 2026Q3: 21,500 shares 21,500$5.36M0.13%-11,000Timeline
CRWDCROWDSTRIKE HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 24,000 shares; 2025Q1: 25,000 shares; 2025Q2: 18,500 shares; 2025Q3: 18,500 shares; 2025Q4: 16,500 shares; 2026Q1: 23,070 shares; 2026Q2: 10,000 shares; 2026Q3: 20,000 shares 20,000$5.29M0.13%+10,000Timeline
NMRANEUMORA THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,396,100 shares; 2025Q1: 4,358,283 shares; 2025Q2: 4,358,283 shares; 2025Q3: 4,358,283 shares; 2025Q4: 6,288,783 shares; 2026Q1: 8,497,822 shares; 2026Q2: 8,497,822 shares; 2026Q3: 8,497,822 shares 8,497,822$5.07M0.12%0Timeline
VTVTVTV THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 163,000 shares; 2025Q4: 163,000 shares; 2026Q1: 163,000 shares; 2026Q2: 163,000 shares; 2026Q3: 163,000 shares 163,000$5.03M0.12%0Timeline
DDOGDATADOG INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 30,425 shares; 2025Q1: 47,425 shares; 2025Q2: 38,425 shares; 2025Q3: 32,925 shares; 2025Q4: 36,425 shares; 2026Q1: 54,300 shares; 2026Q2: 40,000 shares; 2026Q3: 18,000 shares 18,000$4.93M0.12%-22,000Timeline
AGMBAGOMAB THERAPEUTICS NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 411,250 shares; 2026Q2: 411,250 shares; 2026Q3: 411,250 shares 411,250$4.56M0.11%0Timeline
ODTXODYSSEY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 200,000 shares; 2026Q3: 200,000 shares 200,000$4.44M0.11%0Timeline
IVVDINVIVYD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,000,000 shares; 2026Q1: 4,000,000 shares; 2026Q2: 5,000,000 shares; 2026Q3: 5,000,000 shares 5,000,000$4.35M0.1%0Timeline
JMKEJERSEY MIKES SUBS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 250,000 shares 250,000$4.21M0.1%newTimeline
IRENIREN LIMITEDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 20,000 shares; 2025Q4: 43,100 shares; 2026Q1: 43,100 shares; 2026Q2: 175,000 shares; 2026Q3: 100,000 shares 100,000$4.09M0.1%-75,000Timeline
OUSTOUSTER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 67,500 shares; 2026Q3: 100,000 shares 100,000$4.03M0.1%+32,500Timeline
WSEWISE GROUP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 350,906 shares 350,906$4.02M0.1%newTimeline
TTMITTM TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 30,000 shares 30,000$3.69M0.09%newTimeline
KRROKORRO BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 418,833 shares; 2025Q1: 418,833 shares; 2025Q2: 418,833 shares; 2025Q3: 418,833 shares; 2025Q4: 347,718 shares; 2026Q1: 347,718 shares; 2026Q2: 347,718 shares; 2026Q3: 347,718 shares 347,718$3.45M0.08%0Timeline
MNDYMONDAY COM LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 7,000 shares; 2025Q4: 17,000 shares; 2026Q1: 25,000 shares; 2026Q2: 42,500 shares; 2026Q3: 37,500 shares 37,500$2.94M0.07%-5,000Timeline
AEVAAEVA TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 110,000 shares; 2026Q2: 145,459 shares; 2026Q3: 200,000 shares 200,000$2.81M0.07%+54,541Timeline
ASAMER SPORTS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 25,000 shares; 2025Q4: not reported; 2026Q1: 50,000 shares; 2026Q2: not reported; 2026Q3: 100,000 shares 100,000$2.73M0.06%newTimeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,000,000 shares; 2026Q3: 2,000,000 shares 2,000,000$2.7M0.06%0Timeline
FHTXFOGHORN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 720,720 shares; 2025Q1: 720,720 shares; 2025Q2: 720,720 shares; 2025Q3: 720,720 shares; 2025Q4: 720,720 shares; 2026Q1: 720,720 shares; 2026Q2: 720,720 shares; 2026Q3: 720,720 shares 720,720$2.57M0.06%0Timeline
GTLBGITLAB INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 35,000 shares; 2025Q3: 64,000 shares; 2025Q4: 99,000 shares; 2026Q1: 100,000 shares; 2026Q2: 125,000 shares; 2026Q3: 50,000 shares 50,000$2.36M0.06%-75,000Timeline
BACBANK OF AMER CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 40,000 shares 40,000$2.18M0.05%newTimeline
SCHWCHARLES SCHWAB CORP (THE)Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 15,000 shares 15,000$1.47M0.03%newTimeline
FANGDIAMONDBACK ENERGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 7,500 shares 7,500$1.38M0.03%newTimeline
ADAGADAGENE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,666,666 shares; 2026Q3: 421,658 shares 421,658$1.35M0.03%-2,245,008Timeline
MGMMGM RESORTS INTERNATIONALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 43,000 shares 43,000$1.34M0.03%newTimeline
RANIRANI THERAPEUTICS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,000,000 shares; 2026Q1: 2,000,000 shares; 2026Q2: 2,000,000 shares; 2026Q3: 1,594,800 shares 1,594,800$1.26M0.03%-405,200Timeline
FIGFIGMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 15,000 shares; 2025Q4: 25,000 shares; 2026Q1: 50,000 shares; 2026Q2: 50,000 shares; 2026Q3: 50,000 shares 50,000$1.05M0.02%0Timeline
KLRSKALARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 282,586 shares; 2025Q2: 282,586 shares; 2025Q3: 318,264 shares; 2025Q4: 435,798 shares; 2026Q1: 435,798 shares; 2026Q2: 435,798 shares; 2026Q3: 356,559 shares 356,559$1.03M0.02%-79,239Timeline
QNTQUANTINUUM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 20,000 shares; 2026Q3: 20,000 shares 20,000$961K0.02%0Timeline
ZTSZOETIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 35,000 shares; 2026Q3: 12,500 shares 12,500$873K0.02%-22,500Timeline
GOSSGOSSAMER BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 65,112 shares 65,112$772K0.02%newTimeline
PRMBPRIMO BRANDS CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 37,500 shares; 2025Q3: 75,000 shares; 2025Q4: 75,000 shares; 2026Q1: 50,000 shares; 2026Q2: not reported; 2026Q3: 25,000 shares 25,000$476K0.01%newTimeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
MSFTMICROSOFT CORP COMcall24,000$12.3M0

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
DFTXDEFINIUM THERAPEUTICS INC1,419,493$66.8Mshares
CRNXCRINETICS PHARMACEUTICALS IN1,420,788$53.2Mshares
COFCAPITAL ONE FINL CORP171,615$34.4Mshares
SIONSIONNA THERAPEUTICS INC610,515$26.9Mshares
ORKAORUKA THERAPEUTICS INC250,000$23.8Mshares
DMRADAMORA THERAPEUTICS INC900,000$23.4Mshares
MPLTMAPLIGHT THERAPEUTICS INC450,000$16.1Mshares
PDDPDD HOLDINGS INC95,000$7.25Mshares
AAPLAPPLE INC23,000$6.66Mcall
TENXTENAX THERAPEUTICS INC427,141$6.21Mshares
BABAALIBABA GROUP HLDG LTD50,000$4.8Mshares
CLBTCELLEBRITE DI LTD311,544$4.55Mshares
SEERSEER INC2,458,673$4.08Mshares
NBPNOVABRIDGE BIOSCIENCES2,004,739$3.91Mshares
WKWORKIVA INC45,000$2.18Mshares
NFLXNETFLIX INC.25,000$1.78Mshares
TSLATESLA INC3,500$1.47Mshares
BEKEKE HLDGS INC100,000$1.45Mshares
MDLNMEDLINE INC25,000$986Kshares
LITELUMENTUM HLDGS INC1,055$905Kshares
GOSSGOSSAMER BIO INC5,208,968$857Kshares
FOXAFOX CORP10,000$522Kshares
TAT&T INC25,000$518Kshares
NUNU HLDGS LTD25,000$334Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0002005245-26-000013 base2026-11-12